The coccidioidal complement fixation and immunodiffusion-complement fixation antigen is a chitinase

S M Johnson1, D Pappagianis

  • 1Department of Medical Microbiology and Immunology, School of Medicine, University of California, Davis 95616.

Insights

Researchers identified a chitinase from Coccidioides immitis as a key antigen for diagnosing coccidioidomycosis. This enzyme is crucial for serodiagnosis and may play a role in fungal development.

Area of Science:

  • Mycology
  • Immunology
  • Biochemistry

Background:

  • Culture filtrates and autolysates of Coccidioides immitis are used as crude antigens for coccidioidomycosis serodiagnosis.
  • A specific heat-labile antigen, involved in immunodiffusion and complement fixation reactions (IDCF), was previously characterized as a 110-kDa protein yielding a 48-kDa component under reducing and heat conditions.

Purpose of the Study:

  • To provide serologic and biochemical evidence identifying the heat-labile IDCF antigen as a chitinase.
  • To investigate the enzymatic and antigenic properties of this C. immitis chitinase.

Main Methods:

  • Isolation of the antigen from a 48-h culture filtrate of the spherule-endospore-phase C. immitis using affinity adsorption to chitin.
  • Serologic testing including immunodiffusion and complement fixation reactions with human serum.
  • Biochemical analysis of enzymatic and antigenic activity following heat treatment.

Main Results:

  • The isolated chitinase formed a line of identity with the IDCF reference antigen in immunodiffusion.
  • The chitinase participated in the complement fixation reaction with human serum.
  • Enzymatic and antigenic activity were lost upon heating, but enzymatic activity was retained when not heated, even after precipitation with coccidiodal antibody.

Conclusions:

  • The identified chitinase is a significant serodiagnostic substance for coccidioidomycosis.
  • This chitinase may play a role in the morphogenesis of Coccidioides immitis.

Related Concept Videos

Enzyme-Linked Immunosorbent Assay01:33

Enzyme-Linked Immunosorbent Assay

In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen.  Enzyme-substrate reaction allows the antigen to be visualized or quantified.
Immunocytochemistry and Immunohistochemistry01:22

Immunocytochemistry and Immunohistochemistry

Immunocytochemistry (ICC) and immunohistochemistry (IHC) are techniques that use antibodies to check for specific proteins or antigens in a sample. The technique was first published by Albert Coons in 1941 to detect the presence of pneumococcal antigen in tissue sections from mice infected with Pneumococcus. Immunocytochemistry helps localization of proteins or antigens in individual cells like blood cells, stem cells, etc., while immunohistochemistry does the same for tissue samples.
These...
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Complement System01:27

Complement System

The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a membrane...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...